Advertisement
Singapore markets open in 5 hours 34 minutes
  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • Dow

    40,003.59
    +134.19 (+0.34%)
     
  • Nasdaq

    16,685.97
    -12.33 (-0.07%)
     
  • Bitcoin USD

    66,331.28
    -505.48 (-0.76%)
     
  • CMC Crypto 200

    1,354.28
    -19.56 (-1.42%)
     
  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     
  • Gold

    2,419.80
    +2.40 (+0.10%)
     
  • Crude Oil

    80.00
    +0.77 (+0.96%)
     
  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     
  • Nikkei

    38,787.38
    -132.92 (-0.34%)
     
  • Hang Seng

    19,553.61
    +177.11 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     
  • Jakarta Composite Index

    7,317.24
    -7,246.70 (-49.76%)
     
  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

Insider Sale at Encompass Health Corp (EHC): EVP, General Counsel & Secretary John Darby ...

On May 6, 2024, John Darby, EVP, General Counsel & Secretary of Encompass Health Corp (NYSE:EHC), sold 14,543 shares of the company. The transaction was filed on the same day with the SEC.

Encompass Health Corp (NYSE:EHC) specializes in integrated healthcare services, including both facility-based and home-based patient care. The company aims to deliver high-quality, cost-effective care across its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies.

The shares were sold at a price of $83.94, valuing the transaction at approximately $1,220,982.72. Following this transaction, the insider's direct ownership in the company stands at zero shares.

ADVERTISEMENT

Over the past year, John Darby has sold a total of 14,543 shares and has not made any purchases. The insider transaction history for Encompass Health Corp shows 1 insider buy and 5 insider sells over the past year.

As of the latest sale, Encompass Health Corp (NYSE:EHC) has a market cap of $8.66 billion. The stock's price-earnings ratio is 23.25, which is below the industry median of 24.68.

The GF Value of the stock is $69.69, indicating a price-to-GF-Value ratio of 1.2. This suggests that Encompass Health Corp is modestly overvalued based on its GF Value.

Insider Sale at Encompass Health Corp (EHC): EVP, General Counsel & Secretary John Darby Sells 14,543 Shares
Insider Sale at Encompass Health Corp (EHC): EVP, General Counsel & Secretary John Darby Sells 14,543 Shares

The GF Value is calculated considering historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.

Insider Sale at Encompass Health Corp (EHC): EVP, General Counsel & Secretary John Darby Sells 14,543 Shares
Insider Sale at Encompass Health Corp (EHC): EVP, General Counsel & Secretary John Darby Sells 14,543 Shares

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.